Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Teratogenic risks of antiepileptic drugs.

Literature DB >> 6790047

Teratogenic risks of antiepileptic drugs.

Abstract

Mesh：

Substances：

Year: 1981 PMID： 6790047 PMCID： PMC1507911 DOI： 10.1136/bmj.283.6290.515

Source DB: PubMed Journal: Br Med J (Clin Res Ed) ISSN： 0267-0623

× No keyword cloud information.

19 in total

1. Case for Diagnosis.

Authors: J H Sequeira
Journal: Proc R Soc Med Date: 1912

2. Infants exposed in utero to antiepileptic drugs. A prospective study.

Authors: R M Hill; W M Verniaud; M G Horning; L B McCulley; N F Morgan
Journal: Am J Dis Child Date: 1974-05

3. The course and outcome of pregnancy in women with epilepsy.

Authors: T Bjerkedal; S L Bahna
Journal: Acta Obstet Gynecol Scand Date: 1973 Impact factor: 3.636

4. Changing to single drug therapy in epilepsy.

Authors: M P Feely; M N Callaghan
Journal: Lancet Date: 1981-04-11 Impact factor: 79.321

5. Fetal head growth retardation associated with maternal antiepileptic drugs.

Authors: V K Hiilesmaa; K Teramo; M L Granström; A H Bardy
Journal: Lancet Date: 1981-07-25 Impact factor: 79.321

6. Are hydantoins (phenytoins) human teratogens.

Authors: S Shapiro; D Slone; S C Hartz; L Rosenberg; V Siskind; R R Monson; A A Mitchell; O P Heinonen
Journal: J Pediatr Date: 1977-04 Impact factor: 4.406

7. The fetal trimethadione syndrome.

Authors: E H Zackai; W J Mellman; B Neiderer; J W Hanson
Journal: J Pediatr Date: 1975-08 Impact factor: 4.406

8. Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome.

Authors: J W Hanson; N C Myrianthopoulos; M A Harvey; D W Smith
Journal: J Pediatr Date: 1976-10 Impact factor: 4.406

Teratogenic risks of antiepileptic drugs.

1. Case for Diagnosis.

2. Infants exposed in utero to antiepileptic drugs. A prospective study.

3. The course and outcome of pregnancy in women with epilepsy.

4. Changing to single drug therapy in epilepsy.

5. Fetal head growth retardation associated with maternal antiepileptic drugs.

6. Are hydantoins (phenytoins) human teratogens.

7. The fetal trimethadione syndrome.

8. Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome.

9. Anticonvulsants and parental epilepsy in the development of birth defects.

10. The fetal trimethadione syndrome: report of an additional family and further delineation of this syndrome.

1. Women with epilepsy planning pregnancy: we can improve outcomes by improving care.

2. Anticonvulsants in the newborn period.